All In MedTech

FDA Clearance Tracker · P170027-S002

TherOx Downstream System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 11, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 11, 2020

Approved

Time to decision

205 days

Received Aug 19, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P170027-S002
Device name
TherOx Downstream System
Applicant location
San Jose, CA
Received
Aug 19, 2019
Decided
Mar 11, 2020
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P170027

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code MWG

FDA's approval statement

As written in FDA's record.

Approval for the DS-2 Console. The DS-2 Console uses the same cartridge as the DS-1 Console; however, it has updated hardware and software to accommodate a touchscreen display in addition to modified electrical components to comply with the EU RoHS Standard.

Source documents

Other decisions for Zoll Circulation, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.